Abstract:Integrative Cancer Therapies, Volume 23, Issue , January-December 2024. Background:The traditional Chinese medicine (TCM) Xiaoliu Pingyi recipe (XLPYR) has been clinically used for several decades, demonstrating favorable therapeutic effects. However, the underlying regulatory mechanisms remain unclear. The aim of this study was to explore the anti-tumor effects of XLPYR and its regulatory role in the vascular microenvironment through in vivo and in vitro experiment.Materials and methods:In the in vivo study, a C57BL/6J mouse model of lung adenocarcinoma (LUAD) allografts was established, and various interventions were administered for 14 days (Model group: administered normal saline via oral gavage; Pemetrexed (PEM) group: intraperitoneally injected with a solution of pemetrexed, once every 3d; XLPYR group: administered XLPYR via oral gavage; Combination (COMBI) group: received XLPYR via oral gavage simultaneously with intraperitoneal injection of pemetrexed solution). Tumor volume and weight were then compared among the groups. The impact of XLPYR on the tumor vascular microenvironment was assessed using immunohistochemistry staining. In the in vitro study, XLPYR-containing serum was prepared by oral administration to SD rats. The CCK-8 assay evaluated the effect of the serum on the proliferation of normal lung epithelial BEAS-2B cells and LUAD A549 cells, determining the optimal intervention concentrations. The cell migration and invasion abilities were evaluated using the wound-healing assay and Transwell assay, respectively. Finally, ELISA assay measured VEGF secretion levels in the LUAD cell supernatant, and RT-qPCR and Western Blot were employed to detect differences in HIF-1α, VEGFA, Ang-2, and PI3K/Akt mRNA and protein expression levels in both in vivo and in vitro experiments.Results:In the in vivo study, XLPYR significantly inhibited the growth of mice LUAD allografts, with enhanced anti-tumor effects observed with prolonged drug intervention. Immunohistochemistry staining revealed reduced MVD and increased pericyte coverage in all intervention groups. Regarding vascular function, FITC-Dextran extravasation in the tumor tissues of the Model group was significantly higher than in the intervention groups, particularly with lower extravasation in the COMBI group compared to the PEM group. In the in vitro study, XLPYR demonstrated a time- and concentration-dependent inhibitory effect on LUAD cells, and with greater sensitivity in inhibiting LUAD cells compared to BEAS-2B cells. The wound-healing assay and Transwell assay confirmed that XLPYR significantly suppressed the migration and invasion abilities of LUAD cells. ELISA experiments further revealed a significant decrease in VEGF expression in the supernatant of each intervention group. RT-qPCR and Western Blot results showed consistent findings between the in vivo and in vitro experiments. HIF-1α, VEGFA, and Ang-2 mRNA and protein expression levels were significantly downregulated in the PEM group, XLPYR group, and COMBI group. There were no significant differences in the expression of PI3K and Akt mRNA and total protein, but the expression levels of phosphorylated p-PI3K and p-Akt were notably downregulatedConclusion:XLPYR significantly inhibited C57BL/6J mouse LUAD allograft growth and improved the vascular microenvironment, thereby intervening in tumor angiogenesis and inducing vascular normalization. It suppressed LUAD cell proliferation, migration, and invasion, while reducing VEGF concentration in the cell supernatant. The regulatory mechanism may involve inhibiting PI3K/Akt protein phosphorylation and downregulating angiogenesis-related factors, such as HIF-1α, VEGF, and Ang-2.

Anti-tumor Effect of Liqi, a Traditional Chinese Medicine Prescription, in Tumor Bearing Mice.

Influence of Traditional Chinese Compound Recipes with Different Efficacy on Body Weight, Tumor Weight and Immune Function in H22 Cancer-Bearing Mice

Experimental Study on Anti-Tumor Effect with Shenqi Compound Recipe

Comparison of Efficacy and Toxicity of Traditional Chinese Medicine (TCM) Herbal Mixture LQ and Conventional Chemotherapy on Lung Cancer Metastasis and Survival in Mouse Models

Immunomodulatory Activity of 3 Beta,6 Beta-Dihydroxyolean-12-En-27-Oic Acid in Tumor-Bearing Mice

Tumor Inhibiting and Immunoloregulation Effects of "Fuzheng Huoxue Kangai Prescription" on H22 Cancer-Bearing Mice

[Study on the Acute Toxicity Experiment of Mice and Anti-Tumor Function in Vitro of the Qinglongyi].

Effect of Treatment with Yiqi Baidu Recipe on Expression of the Tumor Metastatic Suppressor Gene in Mouse Melanoma Model

Chinese Herbal Prescription QYSL Prevents Progression of Lung Cancer by Targeting Tumor Microenvironment

Effects of Ligustilide on Tumor Growth and Immune Function in Institute of Cancer Research Mice

Yi Qi Chu Tan Formula (YQCTF) inhibited the progress of lung cancer via regulating tumor-associated neutrophil: An integrated study of network pharmacology, proteomics and pharmacodynamics

Predicting the mechanism of action of YQYYJD prescription in the treatment of non-small cell lung cancer using transcriptomics analysis

The Pathomorphous Changes in Lewis' Lung Cancer Mice Treated by Qingjin Desheng Tablets

Wan-Nian-Qing, a Herbal Composite Prescription, Suppresses the Progression of Liver Cancer in Mice by Regulating Immune Response

Chinese Herbal Compound Xiaoliu Pingyi Recipe Inhibits the Growth of Lung Adenocarcinoma by Regulating the Tumor Vascular Microenvironment

Experimental study of anticancer mechanism of Jianpi Liqi Granules in H22 hepatic cancer mice

Effect of Jianpi Liqi priscription combined with rIL-2 on immune supression caused by chemotherapy

Experimental Study on Anti -Tumor Effect of Sijunzi Decoction in Mice with Transplanted Primary Liver Cancer

Intervention of Spleen-Nourishing and Qi-Enriching Herbs on Liver Metastasis of B16 Melanoma Grafted in Mice

Effects of Qingyi Huaji Decoction on Serum Levels of Interleukin-6, Interleukin-8 and Tumor Necrosis Factor-Α in Nude Mice Bearing Pancreatic Tumors

Liquiritigenin Induces Cell Cycle Arrest and Apoptosis in Lung Squamous Cell Carcinoma